Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Parasympathomimetic drug

From Wikipedia, the free encyclopedia
Substance that mimics stimulation of cholinergic receptors
This article is about drugs stimulating parasympathetic system. For drugs inhibiting parasympathetic system, seeparasympatholytics.
icon
This articleneeds additional citations forverification. Please helpimprove this article byadding citations to reliable sources. Unsourced material may be challenged and removed.
Find sources: "Parasympathomimetic drug" – news ·newspapers ·books ·scholar ·JSTOR
(December 2013) (Learn how and when to remove this message)

Aparasympathomimetic drug, sometimes called acholinomimetic drug[1] orcholinergic receptorstimulating agent,[2] is a substance that stimulates theparasympathetic nervous system (PSNS).[3][2] These chemicals are also calledcholinergic drugs becauseacetylcholine (ACh) is theneurotransmitter used by the PSNS.[1][4] Chemicals in this family can act either directly by stimulating thenicotinic ormuscarinic receptors (thus mimicking acetylcholine), or indirectly by inhibitingcholinesterase, promoting acetylcholine release, or other mechanisms.[5] Common uses of parasympathomimetics includeglaucoma,Sjögren syndrome andunderactive bladder.[6]

Somechemical weapons such assarin orVX, non-lethalriot control agents such astear gas, andinsecticides such asdiazinon fall into this category.[citation needed]

Structure activity relationships for parasympathomimetic drugs

[edit]

For a cholinergic agent, the following criteria describe the structure activity relationship:[7]

  1. Ing's Rule of 5: there should be no more than five atoms between the nitrogen and the terminal hydrogen for muscarinic (or cholinergic) activity;
  2. the molecule must possess a nitrogen atom capable of bearing a positive charge, preferably a quaternary ammonium salt;
  3. for maximum potency, the size of the alkyl groups substituted on the nitrogen should not exceed the size of a methyl group;
  4. the molecule should have an oxygen atom, preferably an ester-like oxygen capable of participating in a hydrogen bond;
  5. there should be a two-carbon unit between the oxygen atom and the nitrogen atom.

Pharmaceuticals/Supplements

[edit]

Direct-acting

[edit]

These act by stimulating thenicotinic ormuscarinic receptors.

Indirect-acting

[edit]

Indirect acting parasympathomimetic substances may be either reversible cholinesterase inhibitors, irreversible cholinesterase inhibitors or substances that promote ACh release oranti-adrenergics. The latter inhibits the antagonistic system, thesympathetic nervous system.

See also

[edit]

References

[edit]
  1. ^abDowd, Frank (2017).Pharmacology and therapeutics for dentistry: Chapter 6 - Cholinergic Agonists and Muscarinic Receptor Antagonists. St. Louis, Missouri: Elsevier. pp. 82–97.ISBN 978-0-323-39307-2.OCLC 958121223.
  2. ^abForrester, John V.; Dick, Andrew D.; McMenamin, Paul G.; Roberts, Fiona; Pearlman, Eric (2016). "General and ocular pharmacology".The Eye. Elsevier. pp. 338–369.e1.doi:10.1016/b978-0-7020-5554-6.00006-x.ISBN 978-0-7020-5554-6.Parasympathomimetics are a group of drugs that act either by directly stimulating the muscarinic receptor, for example pilocarpine, or by inhibiting the enzyme acetylcholinesterase, which hydrolyses the acetylcholine in the synapse.
  3. ^"Dorlands Medical Dictionary:parasympathomimetic". Archived fromthe original on 2009-07-26.
  4. ^Parasympathomimetics
  5. ^Brenner, G. M. (2000).Pharmacology. Philadelphia, PA: W.B. Saunders Company.ISBN 0-7216-7757-6
  6. ^Moro, Christian; Phelps, Charlotte; Veer, Vineesha; Clark, Justin; Glasziou, Paul; Tikkinen, Kari A. O.; Scott, Anna M. (2021-11-24). "The effectiveness of parasympathomimetics for treating underactive bladder: A systematic review and meta-analysis".Neurourology and Urodynamics.41 (1):127–139.doi:10.1002/nau.24839.ISSN 1520-6777.PMID 34816481.S2CID 244530010.
  7. ^"Medicinal Chemistry of Adrenergics and Cholinergics". Archived fromthe original on 2010-11-04. Retrieved2010-10-23.
  8. ^Karadsheh, N; Kussie, P; Linthicum, DS (1991). "Inhibition of acetylcholinesterase by caffeine, anabasine, methyl pyrrolidine and their derivatives".Toxicology Letters.55 (3):335–42.doi:10.1016/0378-4274(91)90015-X.PMID 2003276.

External links

[edit]
Types
Classes
Enzyme
Ion channel
Receptor &
transporter
BA/M
Adrenergic
Dopaminergic
Histaminergic
Serotonergic
AA
GABAergic
Glutamatergic
Cholinergic
Cannabinoidergic
Opioidergic
Other
Miscellaneous
mAChRsTooltip Muscarinic acetylcholine receptors
Agonists
Antagonists
Precursors
(andprodrugs)
nAChRsTooltip Nicotinic acetylcholine receptors
Agonists
(andPAMsTooltip positive allosteric modulators)
Antagonists
(andNAMsTooltip negative allosteric modulators)
Precursors
(andprodrugs)
Drugs used forglaucoma preparations andmiosis (S01E)
Sympathomimetics
Parasympathomimetics
muscarinic
muscarinic/nicotinic
acetylcholinesterase inhibitors
Carbonic anhydrase inhibitors/
(sulfonamides)
Beta blocking agents
Prostaglandin analogues (F)
Other agents


Stub icon

Thispharmacology-related article is astub. You can help Wikipedia byadding missing information.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Parasympathomimetic_drug&oldid=1308160854"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2026 Movatter.jp